BTBP's subsidiary received a notice of compliance inspection for drug GMP
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, BTBP announced that its subsidiary Chengdu Rongsheng Pharmaceutical Co., Ltd. (referred to as "Chengdu Rongsheng") has received the "Drug GMP Compliance Inspection Notification" issued by the Sichuan Provincial Drug Administration, involving the workshop for: recombinant product production workshop
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments